Commentary - (2014) Volume 5, Issue 9

The New Science of Abuse-Deterrence Assessment of Pharmaceutical Products; FDA Proposed Guidance and Category 1 Laboratory Studies

Cone EJ, Buchhalter AR*, Henningfield JE and Schnoll SH
Abuse-Deterrent Drug Products, Pinney, Associates, 4800 Montgomery Lane, Suite 400, Bethesda, USA
*Corresponding Author: